Cargando…

Performance of Plasma Amyloid β, Total Tau, and Neurofilament Light Chain in the Identification of Probable Alzheimer's Disease in South China

Background: Alzheimer's disease (AD) is the most common type of dementia and has no effective treatment to date. It is essential to develop a minimally invasive blood-based biomarker as a tool for screening the general population, but the efficacy remains controversial. This cross-sectional stu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jiao, Bin, Liu, Hui, Guo, Lina, Liao, Xinxin, Zhou, Yafang, Weng, Ling, Xiao, Xuewen, Zhou, Lu, Wang, Xin, Jiang, Yaling, Yang, Qijie, Zhu, Yuan, Zhou, Lin, Zhang, Weiwei, Wang, Junling, Yan, Xinxiang, Tang, Beisha, Shen, Lu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8579066/ https://www.ncbi.nlm.nih.gov/pubmed/34776933 http://dx.doi.org/10.3389/fnagi.2021.749649

Ejemplares similares

The role of genetics in neurodegenerative dementia: a large cohort study in South China
por: Jiao, Bin, et al.
Publicado: (2021)

Association of Genes Involved in the Metabolic Pathways of Amyloid-β and Tau Proteins With Sporadic Late-Onset Alzheimer’s Disease in the Southern Han Chinese Population
por: Xiao, Xuewen, et al.
Publicado: (2020)

Clinical features of progressive supranuclear palsy
por: Wen, Yafei, et al.
Publicado: (2023)

Clinical characteristics and genotype-phenotype correlation analysis of familial Alzheimer’s disease patients with pathogenic/likely pathogenic amyloid protein precursor mutations
por: Liu, Yingzi, et al.
Publicado: (2022)

The role of NOTCH3 variants in Alzheimer's disease and subcortical vascular dementia in the Chinese population
por: Guo, Lina, et al.
Publicado: (2021)

Genetic effect of MTHFR C677T, A1298C, and A1793G polymorphisms on the age at onset, plasma homocysteine, and white matter lesions in Alzheimer's disease in the Chinese population
por: Jiang, Yaling, et al.
Publicado: (2021)

The role of vascular dementia associated genes in patients with Alzheimer's disease: A large case–control study in the Chinese population
por: Xiao, Xuewen, et al.
Publicado: (2021)

CYLD variants identified in Alzheimer's disease and frontotemporal dementia patients
por: Xiao, Xuewen, et al.
Publicado: (2022)

GSN gene frameshift mutations in Alzheimer’s disease
por: Jiang, Yaling, et al.
Publicado: (2023)

The associations of APP , PSEN1 , and PSEN2 genes with Alzheimer's disease: A large case–control study in Chinese population
por: Xiao, Xuewen, et al.
Publicado: (2022)

Association of rare variants in neurodegenerative genes with familial Alzheimer’s disease
por: Zhang, Weiwei, et al.
Publicado: (2020)

Rare TBK1 variants in patients with frontotemporal dementia and amyotrophic lateral sclerosis in a Chinese cohort
por: Jiao, Bin, et al.
Publicado: (2018)

Plasma tau, neurofilament light chain and amyloid-β levels and risk of dementia; a population-based cohort study
por: de Wolf, Frank, et al.
Publicado: (2020)

Immunity and amyloid beta, total tau and neurofilament light chain: Findings from a community‐based cohort study
por: Fani, Lana, et al.
Publicado: (2020)

Screening of SOD1, FUS and TARDBP genes in patients with amyotrophic lateral sclerosis in central-southern China
por: Hou, Lihua, et al.
Publicado: (2016)

Plasma Amyloid-β, Total Tau, and Neurofilament Light Chain Across the Alzheimer’s Disease Clinical Spectrum: A Population-Based Study
por: Dong, Yi, et al.
Publicado: (2023)

Tau and neurofilament light‐chain as fluid biomarkers in spinocerebellar ataxia type 3
por: Garcia‐Moreno, Hector, et al.
Publicado: (2022)

Mendelian randomization analyses of smoking and Alzheimer’s disease in Chinese and Japanese populations
por: Zhu, Yuan, et al.
Publicado: (2023)

Associations of plasma phosphorylated tau181 and neurofilament light chain with brain amyloid burden and cognition in objectively defined subtle cognitive decline patients
por: Huang, Yanlu, et al.
Publicado: (2022)

Plasma p-tau181, neurofilament light chain and association with cognition in Parkinson’s disease
por: Batzu, Lucia, et al.
Publicado: (2022)

Plasma tau and neurofilament light chain as biomarkers of Alzheimer's disease and their relation to cognitive functions
por: Abed, Sadiruldeen Sami, et al.
Publicado: (2023)

Neurofilament light chain predicts risk of recurrence in cerebral amyloid angiopathy-related intracerebral hemorrhage
por: Cheng, Xin, et al.
Publicado: (2020)

Machine learning based on Optical Coherence Tomography images as a diagnostic tool for Alzheimer's disease
por: Wang, Xin, et al.
Publicado: (2022)

Longitudinal Associations of Blood Phosphorylated Tau181 and Neurofilament Light Chain With Neurodegeneration in Alzheimer Disease
por: Moscoso, Alexis, et al.
Publicado: (2021)

Characteristics of autonomic dysfunction in neuronal intranuclear inclusion disease
por: Zhou, Lu, et al.
Publicado: (2023)

Amyloid-beta modulates the association between neurofilament light chain and brain atrophy in Alzheimer’s disease
por: Kang, Min Su, et al.
Publicado: (2020)

Pathway Analysis for Plasma β-Amyloid, Tau and Neurofilament Light (ATN) in World Trade Center Responders at Midlife
por: Kritikos, Minos, et al.
Publicado: (2020)

Quantitative susceptibility mapping and blood neurofilament light chain differentiate between parkinsonian disorders
por: Zhang, Piao, et al.
Publicado: (2022)

Blood neurofilament light chain and total tau levels at admission predict death in COVID-19 patients
por: De Lorenzo , Rebecca, et al.
Publicado: (2021)

Serum phosphorylated tau protein 181 and neurofilament light chain in cognitively impaired heart failure patients
por: Traub, Jan, et al.
Publicado: (2022)

Neurofilament light chain and total tau in the differential diagnosis and prognostic evaluation of acute and chronic inflammatory polyneuropathies
por: Kmezic, Ivan, et al.
Publicado: (2022)

Potential Utility of Plasma P-Tau and Neurofilament Light Chain as Surrogate Biomarkers for Preventive Clinical Trials
por: Ferreira, Pamela C.L., et al.
Publicado: (2023)

Clinical value of neurofilament and phospho-tau/tau ratio in the frontotemporal dementia spectrum
por: Meeter, Lieke H.H., et al.
Publicado: (2018)

Plasma neurofilament light chain and amyloid-β are associated with the kynurenine pathway metabolites in preclinical Alzheimer’s disease
por: Chatterjee, Pratishtha, et al.
Publicado: (2019)

Neurofilament heavy chain side arm phosphorylation regulates axonal transport of neurofilaments
por: Ackerley, Steven, et al.
Publicado: (2003)

Posttranscriptional regulation of neurofilament proteins and tau in health and disease
por: Yuan, Aidong, et al.
Publicado: (2023)

Neurofilament light chain: defining the analyte
por: Leckey, Claire A., et al.
Publicado: (2022)

Neurofilament light chain and tau concentrations are markedly increased in the serum of patients with sporadic Creutzfeldt-Jakob disease, and tau correlates with rate of disease progression
por: Thompson, Andrew Geoffrey Bourne, et al.
Publicado: (2018)

A preliminary study about neurofilament light chain and tau protein levels in psoriasis: Correlation with disease severity
por: Okan, Gokhan, et al.
Publicado: (2020)

Consistency analysis and conversion model establishment of mini-mental state examination and montreal cognitive assessment in Chinese patients with Alzheimer’s disease
por: Zhou, Lu, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_1562d18sbj902smc4i4b801p7q